UCAR-T Cells（920th Hospital of Joint Logistics Support Force of People's Liberation Army of China）

N/A

Report date: 2022/12/08 20:00:49

Base Information

Drug NameUCAR-T Cells（920th Hospital of Joint Logistics Support Force of People's Liberation Army of China）
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy > Universal CAR-TCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacementsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesThe 920th Hospital Of Joint Logistics Support Force Of PLA
China Registration ClassN/A

Develop Information

Active CompaniesThe 920th Hospital Of Joint Logistics Support Force Of PLA
Inactive CompaniesN/A
Active IndicationsPurpura, Thrombocytopenic, IdiopathicPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A